medigraphic.com
ISSN 0210-5187 (Electronic)

2014, Number 4-6

<< Back Next >>

Med Cutan Iber Lat Am 2014; 42 (4-6)

Immune privilege of the hair follicle

Lemos PMA, Díaz GCJ, Moreno MLH

Language: Spanish
References: 50
Page: 109-116
PDF size: 321.99 Kb.


ABSTRACT

The immune privileged is a multiple mechanisms that prevent the destruction of an individual’s own cells in certain locations, such as the hair follicle. The collapse of this immune privileged can cause cytotoxic diseases, autoimmune diseases as is the case of alopecia areata and primary cicatricial alopecia.


REFERENCES

  1. Paus R, Nickoloff BJ, Ito T. A «hairy» privilege. TRENDS in Immunology. 2005; 26: 32-40.

  2. Streilein JW, Ohta K, Mo JS, Taylor AW. Ocular immune privilege and the impact of intraocular inflammation. DNA Cell Biol. 2002; 21: 453-59.

  3. Head JR, Neaves WB, Billingham RE. Immune privilege in the testis. I. Basic parameters of allograft survival. Transplantation.1983; 36: 423-31.

  4. Head JR, Billingham RE. Immunologically privileged sites in transplantation immunology and oncology. Perspect Biol Med. 1985; 29: 115-31.

  5. Ito T, Meyer KC, Ito N, Paus R. Immune privilege and the skin. Curr Dir Autoimmun. 2008; 10: 27-52.

  6. Barker CF, Billingham RE. Immunologically privileged sites. Adv Immunol.1977; 25: 1-54.

  7. Streilein JW. Ocular immune privilege: therapeutic oppor-tunities from an experiment of nature. Nat Rev Immunol. 2003; 3: 879-89.

  8. Marinovic MA. Inmunología ocular. Rev Chil Reumatol. 2010; 26: 222-41.

  9. Reynolds AJ, Lawrence C, Cserhalmi-Friedman PB, Christiano AM, Jahoda CA. Trans-gender induction of hair follicles. Nature. 1999; 402: 33-44.

  10. Paus R, Christoph T, Müller-Röver S. Immunology of the hair follicle: a short journey into terra incognita. J Investig Dermatol Symp Proc. 1999; 4: 226-34.

  11. Ito T, Ito N, Bettermann A, Tokura Y, Takigawa M, Paus R. Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol. 2004; 164: 623-34.

  12. Botchkarev VA, Botchkareva NV, Slominski A, Roloff B, Luger T, Paus R. Developmentally regulated expression of alpha-MSH and MC-1 receptor in C57BL/6 mouse skin suggests functions beyond pigmentation. Ann N Y Acad Sci. 1999; 885: 433-39.

  13. Waldmann H. Immunology: protection and privilege. Nature. 2006; 442: 987-88.

  14. Paus R, Ito N, Takigawa M, Ito T. The hair follicle and immune privilege. J Investig Dermatol Symp Proc. 2003; 8: 188-94.

  15. Christoph T, Müller-Röver S, Audring H, Tobin DJ, Hermes B, Cotsarelis G et al. The human hair follicle immune system: cellular composition and immune privilege. Br J Dermatol. 2000; 142: 862-73.

  16. Harrist TJ, Ruiter DJ, Mihm MC Jr, Bhan AK. Distribution of major histocompatibility antigens in normal skin. Br J Dermatol. 1983; 109: 623-33.

  17. Meyer KC, Klatte JE, Dinh HV, Harries MJ, Reithmayer K, Meyer W et al. Evidence that the bulge region is a site of relative immune privilege in human hair follicles. Br J Dermatol. 2008; 159: 1077-85.

  18. Menier C, Riteau B, Dausset J, Carosella ED, Rouas-Freiss N. HLA-G truncated isoforms can substitute for HLA-G1 in fetal survival. Hum Immunol. 2000; 61: 1118-25.

  19. Fuzzi B, Rizzo R, Criscuoli L, Noci I, Melchiorri L, Scarselli B et al. HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol. 2002; 32: 311-15.

  20. Gilhar A, Paus R, Kalish RS. Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest. 2007; 117: 2019-27.

  21. Pamer E, Cresswell P. Mechanisms of MHC class I-restricted antigen processing. Annu Rev Immunol. 1998; 16: 323-58.

  22. Momburg F, Tan P. Tapas in-the keystone of the loading complex optimizing peptide binding by MHC class I molecules in the endoplasmic reticulum. Mol Immunol. 2002; 39: 217-33.

  23. Bouvier M. Accessory proteins and the assembly of human class I MHC molecules: a molecular and structural perspective. Mol Immunol. 2003; 39: 697-706.

  24. Borrego F, Masilamani M, Kabat J, Sanni TB, Coligan JE. The cell biology of the human natural killer cell CD94/NKG2A inhibitory receptor. Mol Immunol. 2005; 42: 485-8.

  25. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 1999; 285: 727-29.

  26. Caillat-Zucman S. How NKG2D ligands trigger autoimmunity? Hum Immunol. 2006; 67: 204-47.

  27. Apte RS, Sinha D, Mayhew E, Wistow GJ, Niederkorn JY. Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. J Immunol. 1998; 160: 5693-96.

  28. Gilhar A. Collapse of immune privilege in alopecia areata: coincidental or substantial? J Invest Dermatol. 2010; 130: 2535-7.

  29. Kos L, Conlon J. An update on alopecia areata. Curr Opin Pediatr. 2009; 21: 475-80.

  30. Ito T, Ito N, Saatoff M, Hashizume H, Fukamizu H, Nickoloff B et al. Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack. J Invest Dermatol. 2008; 128: 1196-206.

  31. Breitkopf T, Lo BK, Leung G, Wang E, Yu M, Carr N et al. Somatostatin expression in human hair follicles and its potential role in immune privilege. J Invest Dermatol. 2013; 133 (7): 1722-30.

  32. Slominski A, Heasley D, Mazurkiewicz JE, Ermak G, Baker J, Carlson JA. Expression of proopiomelanocortin (POMC)-derived melanocytestimulating hormone (MSH) and adrenocorticotropic hormone (ACTH) peptides in skin of basal cell carcinoma patients. Hum Pathol. 1999; 30: 208-15.

  33. Kono M, Nagata H, Umemura S, Kawana S, Osamura RY. In situ expression of corticotropin-releasing hormone (CRH) and proopiomelanocortin (POMC) genes in human skin. Fased J. 2001; 15: 2297-9.

  34. Alkhalifah A, Alsantali A, Wang E, McElwee K, Shapiro J. Alopecia areata up date. Part II. Treatment. J Am Acad Dermatol. 2010; 62: 191-202.

  35. Cohen SM. Current immunosuppression in liver transplantation. Am J Ther. 2002; 9: 119-25.

  36. McElwee KJ, Rushton DH, Trachy R, Oliver RF. Topical FK506: a potent immunotherapy for alopecia areata? Studies using the Dundee experimental bald rat model. Br J Dermatol. 1997; 137: 491-97.

  37. Niederkorn JY. See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Immunol. 2006; 7: 354-59.

  38. Cobbold SP, Adams E, Graca L, Daley S, Yates S, Paterson A et al. Immune privilege induced by regulatory T cells in transplantation tolerance. Immunol Rev. 2006; 213: 239-55.

  39. Simpson E. A historical perspective on immunological privilege. Immunol Rev. 2006; 213: 12-22.

  40. Wahl SM, Wen J, Moutsopoulos N. TGF-beta: a mobile purveyor of immune privilege. Immunol Rev. 2006; 213: 213-27.

  41. Gilhar A, Landau M, Assy B, Shalaginov R, Serafimovich S, Kalish RS. Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdc (scid) mice. J Invest Dermatol. 2001; 117: 1357-62.

  42. Westgate GE, Craggs RI, Gibson WT. Immune privilege in hair growth. J Invest Dermatol. 1991; 97: 417-20.

  43. Ruckert R, Hofmann U, van der Veen C, Bulfone-Paus S, Paus R. MHC class I expression in murine skin: developmentally controlled and strikingly restricted intraepithelial expression during hair follicle morphogenesis and cycling, and response to cytokine treatment in vivo. J Invest Dermatol. 1998; 111: 25-30.

  44. Gilhar A. Collapse of immune privilege in alopecia areata: coincidental or substantial? J Invest Dermatol. 2010; 130: 2535-7.

  45. Pozdnyakova O, Mahalingam M. Involvement of the bulge region in primary scarring alopecia. J Cutan Pathol. 2008; 35: 922-5.

  46. Harries M, Harries J, Meyer K, Chaudhry I, Griffiths C, Paus R. Does collapse of immune privilege in the hair-follicle bulge play a role in the pathogenesis of primary cicatricial alopecia? Clin Exp Dermatol. 2009; 35: 637-44.

  47. Harrie M, Meyer K, Paus R. Hairloss as a result of cutaneous autoimmunity: frontiers in the immune pathogenesis of primary cicatricial alopecia. Autoimmun Rev. 2009; 8: 478-83.

  48. Paus R, Slominski A, Czarnetzki BM. Is alopecia areata an autoimmune- response against melanogenesis-related proteins, exposed by abnormal MHC class I-expression in the anagen hair bulb? Yale J Biol Med. 1994; 66: 541-54.

  49. Chiang YZ, Tosti A, Chaudhry IH, Lyne L, Farjo B, Farjo N et al. Lichen planopilaris following hair transplantation and face-lift surgery. Br J Dermatol. 2012; 166: 666-370.

  50. Paus R, Eichmuller S, Hofmann U, Czarnetzki BM, Robinson P. Expression of classical and non-classical MHC class I antigens in murine hair follicles. Br J Dermatol. 1994; 131: 171-83.




2020     |     www.medigraphic.com